SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001564590-22-000726
Filing Date
2022-01-10
Accepted
2022-01-07 20:15:09
Documents
7
Group Members
CHAMPIONS MANAGEMENT CO., LTD.CHIN-NU LINGEORGE YEHKEELUNG HONGLEEMEI CHENSEA CREST HOLDING CORPTEAL SEA HOLDING CORPTIEN-HUO CHENTOPMUNNITY THERAPEUTICS TAIWAN LTDYAN-HUEI LINYU-HUA LIN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A lch-sc13da.htm SC 13D/A 460994
2 EX-99.1 lch-ex991_10.htm EX-99.1 46089
3 EX-99.2 lch-ex992_11.htm EX-99.2 2888470
4 EX-99.3 lch-ex993_12.htm EX-99.3 3294425
5 EX-99.4 lch-ex994_13.htm EX-99.4 869604
6 GRAPHIC gc02mlljkjlm000002.jpg GRAPHIC 4077
7 GRAPHIC gc02mlljkjlm000001.jpg GRAPHIC 8354
  Complete submission text file 0001564590-22-000726.txt   7578689
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Subject) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90905 | Film No.: 22519385
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2F. NO. 3 YUANQU ST., NANGANG DIST. TAIPEI F5 105
Business Address
Lin Chang-Hai (Filed by) CIK: 0001813691 (see all company filings)

Type: SC 13D/A